Advanced Biomed Stock
Advanced Biomed Inc. Common Stock
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Xiaomin Chen
- Employees
- 31
- Market cap
- $7 M
- IPO
- 06/03/2025
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment. Its diverse product…
Advanced Biomed stock: price history
1D
-18.4%
1W
-25.0%
1M
-48.4%
6M
-17.1%
YTD
-31.8%
1Y
-50.7%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~31% weaker price swings than usual
Ask the agents about Advanced Biomed
Advanced Biomed stock metrics
P/E
-8.81
P/B
0.54
EV/EBITDA
-5.44
RETURN ON EQUITY
-3.5%
NET MARGIN
-10,650.7%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
44.6%
FLOAT SHARES
737,534
AVG. DAILY VOLUME (30D)
30,210
Insider transactions (SEC)
Pau Hung To
Pau Hung To
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Advanced Biomed stock
What does Advanced Biomed do?
Advanced Biomed Inc. Common Stock is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Xiaomin Chen, the company employs around 31 people.
The IPO was on 06/03/2025; the stock trades on NASDAQ under the ticker ADVB.
When does Advanced Biomed report next?
Around past earnings, price swings were roughly -31% stronger than usual.
Does Advanced Biomed pay a dividend?
No, Advanced Biomed currently does not pay a dividend.
Which stocks are comparable to Advanced Biomed?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Advanced Biomed stock analyzed?
Clicking "Analyze stock" lets five strategies assess Advanced Biomed against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.